Stock Analysis
Japan Tobacco Inc.'s (TSE:2914) Intrinsic Value Is Potentially 84% Above Its Share Price
Key Insights
- Japan Tobacco's estimated fair value is JP¥7,656 based on 2 Stage Free Cash Flow to Equity
- Japan Tobacco's JP¥4,170 share price signals that it might be 46% undervalued
- Our fair value estimate is 68% higher than Japan Tobacco's analyst price target of JP¥4,567
Does the November share price for Japan Tobacco Inc. (TSE:2914) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.
Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
View our latest analysis for Japan Tobacco
What's The Estimated Valuation?
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value:
10-year free cash flow (FCF) forecast
2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
Levered FCF (¥, Millions) | JP¥507.8b | JP¥536.1b | JP¥551.0b | JP¥562.3b | JP¥570.1b | JP¥576.3b | JP¥581.1b | JP¥585.1b | JP¥588.4b | JP¥591.3b |
Growth Rate Estimate Source | Analyst x4 | Analyst x4 | Analyst x3 | Analyst x3 | Est @ 1.40% | Est @ 1.07% | Est @ 0.84% | Est @ 0.68% | Est @ 0.57% | Est @ 0.49% |
Present Value (¥, Millions) Discounted @ 4.5% | JP¥486.0k | JP¥491.0k | JP¥482.9k | JP¥471.7k | JP¥457.7k | JP¥442.8k | JP¥427.3k | JP¥411.7k | JP¥396.3k | JP¥381.1k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = JP¥4.4t
The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (0.3%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 4.5%.
Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = JP¥591b× (1 + 0.3%) ÷ (4.5%– 0.3%) = JP¥14t
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= JP¥14t÷ ( 1 + 4.5%)10= JP¥9.1t
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is JP¥14t. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of JP¥4.2k, the company appears quite good value at a 46% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.
Important Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Japan Tobacco as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 4.5%, which is based on a levered beta of 0.839. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Japan Tobacco
- Earnings growth over the past year exceeded the industry.
- Debt is not viewed as a risk.
- Dividend is in the top 25% of dividend payers in the market.
- Earnings growth over the past year is below its 5-year average.
- Annual earnings are forecast to grow for the next 3 years.
- Good value based on P/E ratio and estimated fair value.
- Dividends are not covered by cash flow.
- Annual earnings are forecast to grow slower than the Japanese market.
Looking Ahead:
Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. Why is the intrinsic value higher than the current share price? For Japan Tobacco, there are three essential items you should look at:
- Risks: For example, we've discovered 1 warning sign for Japan Tobacco that you should be aware of before investing here.
- Future Earnings: How does 2914's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the TSE every day. If you want to find the calculation for other stocks just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:2914
Japan Tobacco
A tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally.